Last update:

Oncology & Cancer news

Oncology & Cancer

Scientists show targeting cancer stem cells can prevent gastric cancer recurrence

Scientists from A*STAR Institute of Molecular and Cell Biology (A*STAR IMCB) have identified the specific cells responsible for gastric cancer's tendency to return after treatment. The study also demonstrated that eliminating ...

Oncology & Cancer

Cancer's hidden 'safety switch': Silencing TAK1 gene could boost immunotherapy performance

Australian researchers have discovered that the TAK1 gene helps cancer cells survive attack from the immune system, revealing a mechanism that may limit the effectiveness of immunotherapy treatments.

Oncology & Cancer

New Raman imaging system detects subtle tumor signals

Researchers have developed a new compact Raman imaging system that is sensitive enough to differentiate between tumor and normal tissue. The system offers a promising route to earlier cancer detection and to making molecular ...

Oncology & Cancer

AI can help detect kidney cancer faster

Researchers have developed an AI-based tool that accelerates the detection of kidney cancer. Its effectiveness was validated in a study published in Communications Medicine.

Oncology & Cancer

Subtyping colorectal cancer may improve patient outcome predictions

Colorectal cancer, or CRC, is the world's second most lethal cancer based on the number of deaths, and is the third most prevalent malignant tumor. Doctors and patients have long been hoping for better diagnostics for prognosis, ...

Oncology & Cancer

WISDOM trial weighs risk-based cancer screening

University of California, San Francisco investigators led WISDOM, a randomized comparison of risk-based breast cancer screening and annual mammography. Rates of stage ≥IIB breast cancers met a noninferiority threshold under ...

Oncology & Cancer

Engineered dendritic cells boost cancer immunotherapy

EPFL researchers have successfully engineered cells of the immune system to more effectively recognize cancer cells. The work, covered in two papers, turns the previously lab-based method into a full-blown immunotherapy strategy.

Oncology & Cancer

RNA-based molecule enhances therapies against pancreatic cancer

A research group at the Italian Institute of Technology (IIT-Istituto Italiano di Tecnologia) has identified a candidate molecule that could improve current therapies against pancreatic cancer. The team designed the new molecule, ...

Oncology & Cancer

New risk score helps predict pancreatic cancer recurrence

Cedars-Sinai investigators, leading a multi-institutional team, have developed and validated a tool to predict which patients with pancreatic neuroendocrine tumors (PanNETs) need closer monitoring because their cancer is ...

Oncology & Cancer

How to reduce risk of lymphedema after head and neck cancer

Lymphedema after head and neck cancer is considerably more common than previously assumed and can persist long after cancer treatment has finished. Researchers at Lund University in Sweden have discovered that patients with ...

Oncology & Cancer

New technology reduces false positives in breast ultrasounds

New ultrasound technology developed at Johns Hopkins can distinguish fluid from solid breast masses with near perfect accuracy, an advance that could save patients, especially those with dense breast tissue, from unnecessary ...

Oncology & Cancer

Modern radiotherapy delivers higher doses with fewer sessions

New research from the Australian Radiation Protection and Nuclear Safety Agency (ARPANSA) demonstrates the accuracy of modern radiotherapy techniques used to treat cancer. The study is published in the Journal of Applied ...

Oncology & Cancer

Cold plasma penetrates deep into tissue to fight cancer

Researchers at the Leibniz Institute for Plasma Science and Technology (INP) have collaborated with partners at Greifswald University Hospital and University Medical Center Rostock to demonstrate that cold plasma can effectively ...

Oncology & Cancer

How lymphoma rewires the human genome

Translocations are chromosomal "cut and paste" errors that drive many lymphomas, a type of blood cancer and the sixth most common form of cancer overall. This includes mantle cell lymphoma, a rare but aggressive subtype diagnosed ...

Oncology & Cancer

Genetic study suggests ways to catch blood cancer earlier

As we age, our cells replicate, and the DNA in these cells can acquire mistakes—or mutations—every time the sequence is copied. Most newly acquired mutations are harmless, but some can tip the balance toward cancer development ...

Oncology & Cancer

New study maps out the timeline of DNA damage for multiple myeloma

A new study focused on multiple myeloma, the second most common blood cancer, may lead to better ways to group patients by the state of their DNA and define new subtypes of disease to better predict treatment strategies and ...

Oncology & Cancer

Blocking brain damage may slow glioblastoma growth

Blocking brain damage triggered by a glioblastoma, an aggressive brain cancer, may slow the growth of the cancer and allow the brain to keep working better for longer, according to a new study led by UCL (University College ...